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The ability to biosynthetically produce chemicals beyond what is commonly found in Nature
requires the discovery of novel enzyme function. Here we utilize two approaches to discover
enzymes that enable specific production of longer-chain (C5–C8) alcohols from sugar.
The first approach combines bioinformatics and molecular modelling to mine sequence
databases, resulting in a diverse panel of enzymes capable of catalysing the targeted reaction.
The median catalytic efficiency of the computationally selected enzymes is 75-fold greater
than a panel of naively selected homologues. This integrative genomic mining approach
establishes a unique avenue for enzyme function discovery in the rapidly expanding sequence
databases. The second approach uses computational enzyme design to reprogramme
specificity. Both approaches result in enzymes with 4100-fold increase in specificity for the
targeted reaction. When enzymes from either approach are integrated in vivo, longer-chain
alcohol production increases over 10-fold and represents495% of the total alcohol products.
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A
central goal of the bioeconomy is to reduce our
dependence on petroleum through next-generation bio-
manufacturing1. The USDA projects the industrial
production of bio-based specialty chemicals to reach B$340
billion USD by 2025, replacing half of our needs for these
products from petroleum2. To accomplish this ambitious goal,
non-natural biochemical pathways are needed. An example of
one such a pathway is the ‘synthetic recursive þ 1’ carbon
elongation pathway that has been developed to produce a variety
of alcohol products in Escherichia coli3,4. The primary product
from the current pathway is 1-butanol, with longer-chain alcohols
(for example, pentanol, hexanol, heptanol and octanol) being
either minor products of the pathway or not produced at all3,4.
Yet, there is significant interest in producing longer-chain
alcohols, given their use as specialty chemicals5, as well as their
greater energy density when used as liquid fuels or fuel additives.
To produce longer-chain alcohols through the synthetic recursive
þ 1 carbon elongation pathway, we demonstrate that modulating
the specificity of a single enzyme in the pathway could redirect
metabolic flux towards longer-chain alcohols.
In the current synthetic recursive þ 1 pathway, the enzymes
LeuA, LeuB, LeuC and LeuD (collectively known as LeuABCD)
are recruited to recursively elongate 2-ketobutyrate into long-
chain 2-ketoacids3,4. These 2-ketoacids are then converted to
aldehydes by ketoisovalerate decarboxylase6 (KIVD) and
subsequently to alcohols by alcohol dehydrogenase3 (ADH;
Fig. 1). In this engineered pathway, the primary determinant
for the final product chain length is the number of cycles through
LeuABCD7.
Previous efforts to engineer the product specificity of this
pathway have focused on broadening the specificity of LeuA and
KIVD3. When the specificity of LeuA is broadened, additional
cycles through the pathway are carried out, resulting in a mixture
of C2–C6 linear and branched alcohols3. When the specificity of
both LeuA and KIVD are broadened, C2–C8 products are
produced with major products being butanol and pentanol4. To
enhance longer-chain alcohol production, we focused on
discovering a ketoacid decarboxylase specific for long-chain
ketoacids. By replacing KIVD with an enzyme specific for long-
chain ketoacids, the short-chain substrates were able to re-enter
the þ 1 iteration cycle until their conversion to long-chain
ketoacids, which are then decarboxylated and reduced into longer
chain alcohols.
We employed two computationally directed approaches to
discover a decarboxylase with the desired functional profile. The
first is a new approach to mine the rapidly growing sequence
databases. The majority of these proteins derived from the
genomic sequencing of organisms (that is, genomic enzyme
orthologues: GEOs) have not been experimentally characterized.
Therefore, neither function nor specificity is known. Previous
efforts to mine GEOs for function have relied on random
sampling or sequence-based bioinformatics over an entire
enzyme family8–10. These methods require a large number of
genes to be produced and experimentally characterized. To enable
a more efficient sampling method, we developed a novel
computational pipeline that integrates molecular modelling and
bioinformatics to forward predict GEOs’ ability on carrying out
the function of interest. Using this integrative genomic mining
approach we identify a set of ketoacid decarboxylases diverse in
sequence, but capable of utilizing 2-ketooctanoate (C8) as a
substrate. In addition, we demonstrate that the median activity of
GEOs selected using the integrative genomic mining approach is
75-fold greater than a set of naively selected proteins from the
enzyme family. The second approach focuses on reprogramming
the substrate specificity of KIVD by using computational enzyme
design methods. Using the Rosetta Molecular Modeling Suite to
direct the generation and screening of over 400 mutants results in
the discovery of a mutant with 4600-fold increase in specificity
for C8 (ref. 11). Finally, the most specific and active enzyme
from each approach is incorporated into the synthetic recursive
þ 1 pathway to evaluate their ability to modulate in vivo
alcohol production. Both enzymes result in a complete
switch of the alcohol production profile towards longer chain
alcohols, demonstrating the ability to rationally control
biosynthetic product specificity for chemicals not commonly
found in Nature.
Results
Integrative genomic mining for enzyme function. KIVD
belongs to the TPP enzyme family that is composed of more than
17,000 sequences12. To identify GEOs with the desired function
within this vast sequence space, we combined bioinformatics13
and molecular modelling14 with functional constraints to guide
our exploration (Fig. 2). First, ketoacid decarboxylase GEOs were
identified based on sequence similarity to the KIVD used in the
current synthetic recursive þ 1 pathway. At the time the search
was performed, 2,082 sequences were found in the non-
redundant sequence database as significant matches. To broadly
search KIVD sequence space, redundant sequences were filtered
out with a sequence identity cutoff of 90% (ref. 15). Sequences
derived from eukaryotic organisms were removed to increase the
likelihood of producing soluble proteins in E. coli where the
synthetic recursive þ 1 pathway has been implemented.
We assumed that all potential scaffolds with the desired
function should be structurally homologous to KIVD, and further
refined our sequence set accordingly. Since crystal structures for
most of these predicted proteins are not available for analysis, we
produced homology models to obtain a predicted ternary
structure. Using Rosetta Comparative Modeling, one hundred
models were generated for each of the 239 GEOs14. The lowest-
energy model was selected as the representative for each GEO and
evaluated for structural similarity to KIVD. We used the TMalign
algorithm16 to overlay the models with the native KIVD crystal
structure, and only those with a TMalign score of 40.5 were
kept. These bioinformatics and structural filters result in 239
GEOs as candidates for the targeted function (Supplementary
Table 1). The pairwise identity of every sequence to each other
was calculated and the mode of these values lies near 20% (Fig. 2).
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Figure 1 | The synthetic recursive þ 1 pathway. This pathway employs
enzymes LeuABCD from leucine biosynthesis for carbon-chain elongation
of 2-ketoacids. The enzyme KIVD performs the decarboxylation of
2-ketoacids and diverts carbon out from the þ 1 iterative cycle.
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Thus, the selected set of 239 GEOs represents a diverse sampling
of sequence space for this fold family.
To further enrich the set for GEOs likely to function on C8, we
docked a modelled reaction intermediate of the C8 substrate within
the predicted active site (Fig. 2). The lowest-energy model for each
GEO was used as a template for docking a modelled C8
intermediate with functional constraints, which ensured a
productive geometric orientation between the predicted catalytic
residues in the protein and intermediate. The C8 reaction
intermediate used for docking is based on the synthetic thiamine
pyrophosphate (TPP) analogue from a crystal structure of KIVD
(PDB ID: 2VBG), which mimics the initial nucleophilic attack by
the thiazolium17. Docking calculations were carried out using
Rosetta Design in which both the identity and conformation of
non-catalytic residues within the active site were allowed to change,
and the backbone was allowed to move during minimization.
Although the C8 intermediate may be docked without the
introduction of mutations, the design was enabled during the
simulations to allow for the possibility of introducing conservative
mutations that significantly reduce interface energy. After docking
and design simulations, the calculated interface energy was used to
evaluate each GEO’s ability to accommodate C8.
A phylogenetic tree based on sequence similarity was built for
the 239 GEOs in which the lowest protein–ligand interface energy
from the Rosetta Design simulation for each GEO are depicted
(Fig. 2). The bar height above each GEO leaf is proportional to
the lowest interface energy from all 239 GEOs, the higher the bar
the lower the energy. On the basis of the calculated energies it is
immediately apparent that a cluster of GEOs distant in sequence
to KIVD (B15% sequence identity) is predicted to be capable of
utilizing C8. The enzyme with the lowest energy, GEO 175, is a
predicted protein in the genome database with no known
function. The enzyme with the closest amino-acid sequence
identity to GEO 175 (B50% sequence identity) for which
significant biophysical characterization has been performed is
benzoylformate decarboxylase from bacteria Pseudomonas putida
(ppBFD)18. A structural analysis of the active site of ppBFD and
GEO 175 reveals that the active sites are only 50% identical in
sequence (Supplementary Fig. 1), and the activity of ppBFD on
C8 has not been previously studied.
From the design simulations, 10 GEOs were chosen for
experimental characterization based on the predicted protein–
ligand interface energy as well as sequence diversity (Fig. 2 and
Supplementary Table 1). Before ordering these GEOs, each
mutation introduced through the Rosetta Design simulations was
manually analysed. Mutations introduced during the design
simulations were reverted if they were not found to significantly
enhance the calculated Rosetta interface energy. Synthetic genes
encoding each enzyme was obtained, expressed in E. coli and
purified for in vitro kinetic characterization using a panel of
2-ketoacid substrates of different chain lengths including C8, C5,
C3 and the natural substrate for KIVD, ketoisovaleric acid
(Fig. 3). Out of the 10 selected GEOs, 6 (GEO 41, 74, 110, 175,
179 and 195) express and are able to be purified in a soluble form
using our standardized method. Of these six, three exhibit
detectable activities on at least one of the four ketoacids used for
kinetic characterization.
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Figure 2 | The computationally directed genomic enzyme-mining pipeline. GEOs were identified based on amino-acid sequence homology to KIVD.
Bioinformatics filters were used to identify a set of amino-acid sequences from genomic databases that are predicted to be KIVD homologues and likely to
be decarboxylases. Once identified, homology models were built to obtain a predicted ternary structure of each GEO. Ligand docking and design
simulations were subsequently run in the presence of our target ligand (for example, C8) to evaluate the potential protein–ligand interface energy. A
phylogenetic tree for the 239 GEOs is depicted with a bar chart above each sequence. The bar height indicates the predicted protein–ligand interface
energy; the higher the bar the lower the energy. Bar height is scaled linearly relative to the lowest protein–ligand interface energy. Ten GEOs (brown) were
selected for experimental characterization. The pairwise sequence identity of all 239 GEOs to each other has a mode of 20%, indicating the high level of
sequence diversity within this set of sequences.
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Figure 3 | Characterized reaction specificities. (a) KIVD utilizes
various ketoacids as substrates to produce the corresponding aldehyde.
(b) Ketoacids used for in vitro kinetic constant characterization in addition
to 2-ketoisovaleric acid.
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Among the active GEOs, the enzyme with the highest efficiency
on C8 is the computationally top ranked GEO 175, with a kcat/KM
of 17,000M 1s 1 (Table 1 and Fig. 4). This is only twofold
lower than the efficiency of native KIVD on C8. However, GEO
175’s catalytic efficiency on C8 is 33,000-fold higher than that on
C3 and 354-fold higher than that on C5. When assayed under the
same conditions, native KIVD’s catalytic efficiency on C8 is
762-fold higher than that on C3 and 3.4-fold higher than that on
C5. This corresponds to over a 100-fold improvement in
specificity (C8 versus C5) relative to the native KIVD.
To evaluate whether the integrative genomic mining approach
enriches the mining for C8 activity, an additional set of previously
characterized ketoacid decarboxylases diverse in sequence were
experimentally characterized in an equivalent manner. Five
enzymes were selected (PDB: 1OVM, 2VBI, 3FZN, 1ZPD and
1OZF) and all were found to have detectable activity on at least
one of the four ketoacids used for GEO characterization. The
median C8 activity from the GEOs selected using the integrative
genomic mining approach is 75-fold higher than the naively
picked decarboxylases (Table 1 and Fig. 4). This indicates that the
integrative genomic mining approach is effective in identifying
functional enzymes that perform the desired reaction on C8.
The amino-acid sequence for GEO 175 is not predicted to
require any mutations to be capable of utilizing the C8 substrate,
and therefore represents the native enzyme from Streptomyces sp.
C. Comparing the active-site pocket of GEO 175 with native
KIVD (16.8% identity to each other) reveals significant shape
differences (Fig. 5). On the basis of molecular modelling, GEO
175 is predicted to have an extended active site that is
significantly more open to solvent relative to native KIVD. This
results in the predicted binding mode for C8 to be extended in
GEO 175 as opposed to a ‘wrapped’ conformation in KIVD. In
GEO175, the third through fifth carbons of the C8 ketoacid ligand
are predicted to occupy a solvent-exposed, open pocket with
limited molecular interactions. However, the sixth through eighth
carbons are predicted to interact with a narrow and hydrophobic
pocket. Contrary to GEO 175, KIVD has an enclosed hydro-
phobic binding pocket and is predicted to make molecular
interactions throughout the ketoacid alkyl chain (Figs 5 and 6).
On the basis of these observations we engineered a mutant of
GEO 175 containing two amino-acid changes (L376T and T240S)
predicted to remove the direct molecular interactions with
seventh and eighth carbons of the ketoacid alkyl chain, while
maintaining overall protein stability. On kinetic characterization,
we found that the mutant protein’s catalytic efficiency on C8 is
15-fold lower than GEO 175, but the decrease in efficiency for C5,
C3 and isoC5 assayed under the same conditions is 2-fold or less
(Table 1 and Fig. 6). The ability to rationally modulate activity
Table 1 | Enzyme kinetic constants of native, designed and discovered ketoacid decarboxylases.
kcat/KM(M
 1 s 1) C3 C5 C8 iso C5
GEO179 0.9±0.02 100±15 1,200±130 41±1.2 Discovered
GEO195 2.4±0.1 200±14 1,400±160 8±0.3 Discovered
GEO175 0.51±0.02 48±3.7 17,000±2,700 3.3±0.2 Discovered
GEO175 L376T_T240S 0.27±0.02 30±7.2 1,100±160 1.6±0.1 Designed
1OVM 32±0.5 2,100±420 80,000±4,300 1,300±130 Native
2VBI 5,700±1,400 52±1.8 14±0.8 1.8±0.1 Native
3FZN 5.4±0.1 1,700±110 350±30 110±10 Native
1ZPD 8,200±545 140±5.6 19±2 0.33±0.01 Native
1OZF n.d. 0.53±0.04 n.d. 17±0.9 Native
Native KIVD 42±0.6 9,500±470 32,000±5,500 14,000±1,100 Native
KIVD_VLV 0.71±0.07 1.3±0.2 2,800±860 0.24±0.02 Designed
kcat (s
 1)
GEO179 n.d. 0.47±0.03 0.32±0.01 0.39±0.01
GEO195 n.d. 0.49±0.01 0.56±0.02 0.072±0.001
GEO175 n.d. 0.97±0.04 10.1±0.6 n.d.
GEO175 L376T_T240S n.d. 0.28±0.04 3.4±0.2 n.d.
1OVM 0.2±0.01 1±0.1 1.7±0.1 7.8±0.4
2VBI 25±2.6 n.d. 0.051±0.01 0.025±0.001
3FZN n.d. 4.7±0.1 1.3±0.1 0.52±0.02
1ZPD 46.7±1.4 0.95±0.02 0.021±0.001 n.d.
1OZF n.d. n.d. n.d. 0.03±0.001
Native KIVD n.d. 14.3±0.2 7±0.3 61±2.1
KIVD_VLV n.d. 0.013±0.001 0.5±0.03 n.d.
KM (mM)
GEO179 n.d. 4.6±0.6 0.27±0.03 9.4±0.2
GEO195 n.d. 2.5±0.2 0.4±0.04 9.1±0.3
GEO175 n.d. 20±1.3 0.58±0.09 n.d.
GEO175 L376T_T240S n.d. 10±2 3.1±0.4 n.d.
1OVM 7.5±0.1 0.5±0.1 0.021±0.001 6.1±0.6
2VBI 4.3±1.0 n.d. 3.6±0.2 14±0.5
3FZN n.d. 2.7±0.2 3.8±0.3 4.9±0.3
1ZPD 5.7±0.3 7.1±0.3 1.2±0.1 n.d.
1OZF n.d. n.d. n.d. 1.8±0.1
Native KIVD n.d. 1.5±0.1 0.21±0.04 4.5±0.3
KIVD_VLV n.d. 10±1 0.18±0.05 n.d.
The kinetic constants were determined, as described in Methods, against 2-ketooctanoate (C8), 2-ketoisovalerate (isoC5) and pyruvate (C3). The curves consisted of at least five points. The limit of
detection under the conditions tested was 0.2M 1 s 1, kinetic constants beyond our detection limit are labeled as n.d. (not determined). Michaelis–Menten curve fits are shown in Supplementary
Figs 3–6. Errors are shown as ±one s.d.
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based on structure supports the accuracy of the GEO 175
molecular model and the hypothesis that the specificity of GEO
175 can be attributed to a combination of hydrophobic
interactions with the sixth through eighth carbons of the alkyl
chain, while lacking interactions with the third through fifth
carbons (Fig. 6).
Computationally directed KIVD-active-site redesign. In our
second approach to improve the specificity of KIVD, we used
Rosetta Design methods to explore the potential active-site
sequence space that would accommodate 2-ketooctanoate as a
substrate11. Design simulations were carried out with the same
reaction intermediate and functional constraints utilized in the
genomic mining pipeline. Ten residues in the active site were
targeted for mutagenesis. At each site, one of eleven relatively
hydrophobic amino acids (Val, Leu, Ile, Met, Phe, His, Gly, Ala,
Thr, Tyr and Trp) was systematically introduced, and the
remaining nine sites were allowed to be redesigned. The
identities of amino acids at all other residues were kept
constant (Fig. 7). The sequence profile from the 50 lowest-
energy designs was used to guide the construction of a small
library of roughly 400 KIVD mutants from the original
combinatorial space of over 1011 possible active-site mutations.
Since KIVD can already efficiently utilize C8 as a substrate,
enzyme specificity is of primary importance. Therefore, each
mutant was screened against a panel of 2-ketoacid substrates to
assess the specificity and activity of each mutant (Supplementary
Fig. 2). This assay was performed using a high-throughput pH-
dependent colorimetric assay of enzyme activity in crude cell
extracts. Mutations that increased specificity for C8 were then
combined to produce combinatorial mutants and screened for
specificity with the colorimetric assays. The mutant that exhibits
the highest specificity and activity is G402V/M538L/F542V
(KIVD_VLV). Kinetic constant characterization on purified
enzymes shows that the engineered enzyme KIVD_VLV has a
600-fold improvement in specificity between C8 and C5, in terms
of catalytic efficiency, relative to the native KIVD (Table 1).
In vivo testing of longer-chain alcohol production. The mea-
sured specificity and activity for each enzyme was used to select
two candidates for further characterization of their ability to
modulate alcohol production in vivo. The two enzymes with the
highest activity and specificity (Fig. 4), KIVD_VLV and GEO 175,
were tested for their ability to reprogramme the synthetic
recursive þ 1 pathway to produce longer-alcohol products
in vivo. The alcohol-producing biochemical pathway was adapted
from a previous study used to synthesize alcohols of various
a b 
c d 
Figure 5 | Molecular model of the C8 intermediate docked into KIVD and
GEO 175. Cross-sections of the space-filled active site are represented for
KIVD (a) and GEO 175 (b). The C8 ketoacid and TPP ligand are shown in
brown and grey, respectively. The relative orientation of the C8 ligand to the
TPP cofactor represents one conformation of the reaction intermediate
used in the simulations; additional details are provided in Methods. A
detailed view of the amino acids within the active site are illustrated for
KIVD (c) and GEO 175 (d). Residues within 5Å of C8 ligand are shown in
sticks and their corresponding C-alpha are shown in spheres. Figure was
generated using PyMol v1.7.4 (ref. 34).
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The substrate 2-ketooctanoate carbon chain numbering referred to in the
text is numbered in white. According to the molecular model of GEO 175,
the double mutation L376T_T240S is predicted to recede the pocket by
1.4Å and remove interactions between the binding pocket and carbon 8 of
the ketoacid alkyl chain. This mutant was observed to decrease catalytic
efficiency on C8, but has a negligible effect on shorter-chain substrates.
Errors are shown as ±one s.d.
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Figure 4 | Catalytic efficiency and specificity of characterized ketoacid
decarboxylases. Specificity factor is calculated as logC8logC5þ logC8logC3 where the
log-scaled catalytic efficiencies for C8 relative to C5 and C3 are compared.
The three active GEOs and the naively selected set of decarboxylases are
represented in gold (circles) and green (diamonds), respectively. Native
KIVD and KIVD_VLV are depicted in black (square) and blue (triangle),
respectively. 1OZF is not included in this figure since activity on C8 is below
our limit of detection. The genomic mining method and computational
active-site redesign approach both produced enzymes with enhanced
specificity relative to native KIVD.
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lengths3,4. Starting from glucose, the aforementioned þ 1
pathway, involving LeuABCD, recursively elongates 2-ketoacids,
starting with 2-ketobutyrate, into long-chained 2-ketoacids. These
2-ketoacids are then converted to aldehydes by ketoacid
decarboxylases (native KIVD, KIVD_VLV and GEO 175) and
subsequently to alcohols by an ADH. The carbon flux through
this alcohol-synthesizing biochemical pathway is enhanced by
overexpressing thrABC, ilvA, LeuABCD and ADH6 on inducible
plasmids transformed into E. coli3. The effects of overexpression
were, furthermore, supported and maintained by knocking out
the threonine exporter enzyme RhtA and the primary DNA
recombination degradation enzyme RecA. The enzyme AdhE was
also knocked out, which helps raise longer-chain alcohol
production by eliminating a competing pathway where acetyl-
CoA is directly converted to ethanol19.
Consistent with previous reports, the primary products (82% of
total alcohol production) with native KIVD are short alcohols
(C2–C4; Fig. 8 and Supplementary Table 2). The KIVD_VLV triple
mutant completely switches the product profile of this pathway to
predominantly longer-chain (ZC5) alcohols at 728mg l 1.
Hexanol (C6) is the major alcohol detected at a titre of 341mg l 1
(47%), with titres of 269mg l 1 (37%) heptanol (C7), and
118mg l 1 pentanol (16%) also observed. GEO 175 also switches
the product profile of the pathway so that longer-chain alcohols
are the primary products and produced at a level of 522mg l 1.
For GEO175, the product profile is further shifted, resulting in
heptanol (C7) as the major product at a titre of 274mg l 1 (50%),
with hexanol production at 160mg l 1 (29%) and 88mg l 1
pentanol (16%). Similar to the results for KIVD_VLV, no ethanol
or propanol production is observed, and only 19mg l 1 butanol is
produced. In addition, 10mg l 1 of octanol was also observed, a
product not observed when either native KIVD or KIVD_VLV
were tested under equivalent conditions. The in vivo butanol and
octanol titres for GEO175 compared with KIVD_VLV are
consistent with the in vitro enzyme kinetics in which GEO175
has a significantly higher activity on C8, but lower specificity
relative to C5, than KIVD_VLV. Total longer-chain alcohol titres
for both GEO 175 and KIVD_VLV are increased significantly in
comparison with native KIVD, with a 410-fold increase in
heptanol production in both cases, and a 495% yield of longer-
chain alcohols.
Replacing KIVD with GEO 175 or KIVD_VLV results in a
significant increase in longer-chain alcohol production; however,
the overall alcohol production dropsB10-fold from the 4.0 g l 1
obtained with KIVD. We hypothesized that a potential reason for
this could be due to the toxicity of longer-chain alcohols. To
explore the potential of toxicity being a limiting factor in alcohol
production, E. coli growth was monitored over a 7-h incubation
with 10–1,000mg l 1 C5–C8 alcohols supplemented at the
beginning of growth (Fig. 9). Longer-chain alcohols are observed
to be toxic as the supplemented concentration of C6–C8 alcohols
reaches 250mg l 1. The final optical density (OD) of E. coli
cultures drops from 1.9 to B1.6 for C6 and C7 alcohols, and 1.0
for C8. At 500mg l 1 the OD drops to 1.0 and 0.1 for C6 and C7
alcohols, respectively. No significant growth is observed for C8. At
1,000mg l 1 no significant growth is observed for heptanol, and
only an OD of 0.2 is achieved in the presence of hexanol.
However, growth up to an OD of 1.5 is observed for pentanol.
Significant toxicity in the range of 250–1,000mg l 1 for longer-
chain alcohols is consistent with the level of longer-chain alcohol
titre, roughly 500mg l 1, produced in the engineered E. coli
strains. This result indicates that to achieve higher total alcohol
titre with this pathway, a strain of E. coli with high tolerance
towards longer-chain alcohols is likely necessary20,21. However,
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similar issues with product toxicity have been addressed through
the design of continuous extraction methods and could be applied
to the system here to increase levels of longer-chain alcohols
titres22.
Discussion
In this study we introduce an integrative genomic mining
approach to enable the discovery of enzymes for a targeted
function from sequence databases. The function of interest here
was an enzyme with high activity for the decarboxylation of long-
chain ketoacids to modulate the carbon flux of a synthetic
pathway and increase titres of longer alcohols. The integrative
genomic mining approach led to the discovery of a previously
uncharacterized protein that we demonstrate has the targeted
functional properties, and only required experimental character-
ization of 10 new proteins. In parallel, a more traditional
computationally directed library-screening approach was utilized
to reengineer the activity of a well-established enzyme. This
required two successive rounds of screening over 400 mutants
against a panel of substrates to identify an enzyme with the
desired functional properties. When evaluated for their ability to
modulate the carbon flux in vivo, both are able to completely shift
the product profile towards longer-chain alcohols. However, the
genomic mining approach provides a viable alternative to often
expensive and laborious enzyme-engineering efforts that require
screening libraries of mutants. This new approach for mining
protein databases for enzymes of novel function stands to become
an increasingly powerful approach as the methods for protein
modelling improve and the size of genomic databases grow.
The enzyme GEO 175 represents the product of a general and
rapid approach for obtaining enzymes with a desired function
from the rapidly growing sequence databases. By combining
bioinformatics and molecular modelling, this approach enables
the identification of proteins likely to carry out a targeted
function regardless of their native or putatively annotated activity.
This overcomes issues with misannotation of protein function23
or biased assumptions based on the closest characterized protein
in the amino-acid sequence. The enzyme identified in this study,
GEO175, is a clear illustration of this as it is roughly 15% identical
to KIVD and its closest characterized sequence homologue
(ppBFD, roughly 50% sequence identity) has a significantly
different functional profile.
While GEO175 and KIVD_VLV both increased longer-chain
alcohol titre 410-fold, we identified that toxicity needs to be
addressed to further increase total longer alcohol titre. The titre of
longer-chain alcohols produced is on the order of 0.5 g l 1, which
we then demonstrate is highly toxic for the cell lines used in this
study. For industrial applications, bio-alcohol production often
requires titres on the order of over tens of grams per litre (ref. 24).
To avoid the need of a continuous extraction fermentation
system, future efforts for increasing longer-chain alcohol
production should focus on engineering or finding E. coli
strains that are tolerant to this level of product formation.
Efforts to integrate pumps and reengineer the cell wall to be
resistant to alcohols could potentially mitigate toxicity effects and
concurrently enable higher titres of longer alcohols to be
produced through this pathway20,21.
In addition to toxicity we observed that KIVD_VLV exhibits
substrate inhibition kinetics above 2mM (0.3 g l 1) of C8.
This could be another potential cause of total alcohol titre loss
observed in vivo. Redesigning KIVD_VLV to alleviate inhibition
would be important for alcohol production at an industrially
relevant level with this variant. However, the commensurate
specificity and sixfold greater catalytic efficiency possessed by
GEO_175 (relative to KIVD_VLV) make it a prime candidate for
future industrial strain development for longer-chain alcohol
production.
In summary, a new genomic mining approach and computa-
tionally directed library design efforts were both successfully
implemented to obtain enzymes that enabled specific production
of longer-chain alcohols in vivo. These results demonstrate the
modularity of the synthetic þ 1 recursive pathway and provided a
clear path forward to engineer the industrial-level production of
longer alcohols. Finally, the integrative genomic mining approach
introduced here is highly general, and with the rapid growth of
sequence databases it has the potential to revolutionize the
development and discovery of enzyme catalysts.
Methods
Integrative genomic mining. To obtain the GEO sequences, the native KIVD
sequence was input for a homologous sequence search using HMMER3’s* online
server13. The resulting sequences were filtered using the CD-HIT* online server
with a 90% identity cutoff15,25 (Supplementary Figs 7 and 8). A homology model of
each sequence was made using Rosetta Comparative Modeling14. At this point, the
intermediate was placed into the active site, and 1,000 simulations were run to relax
the intermediate according to the constraints. For each model, the lowest 100 in
overall protein energy models were selected and then from that subset the lowest
protein–ligand interface was chosen as the energy for the GEO.
An intermediate of the C8 product-yielding reaction was modelled using
Spartan* (ref. 26). This intermediate is modelled based on the synthetic TPP
analogue from a crystal structure of KIVD (PDB ID: 2VBG), which mimics the
initial nucleophilic attack by the thiazolium. The six-carbon alkyl chain and the
acid were added to the structure of the TPP analogue within Spartan. Different
conformations of the alkyl chain were included in the modelling and a
conformational library was made using OpenEye Omega* (ref. 27). For the enzyme
design of KIVD, this intermediate was placed into the active site using distance and
angle constraints. Rosetta Enzyme Design was run with default settings, an example
of which is provided in the Rosetta Molecular Modeling Suite demos.
From the design simulations for each GEO, the lowest protein–ligand interface
Rosetta energy was used to select a tractable number of GEOs for experimental
characterization. During these simulations, any amino acids with a Ca within 8Å of
the active site could be mutated to any of the 20 amino acids. Ten GEOs of
significant interest were chosen with the following criteria: five GEOs were chosen
because they had the lowest predicted energies; the second five were chosen with
the purpose of maximizing sequence space diversity. The 234 GEOs (less the five
lowest in energy) were filtered with a sequence identity cutoff of 40%, and the five
sequences from this filtered list with the lowest energy were picked as the second
five GEOs in our final list. Each model was evaluated in the Foldit interface, and
mutations made during the design simulations were reverted to the native amino
acid if not predicted to improve the interface energy by more than two Rosetta
energy units.
Phylogenetic tree of GEOs was generated with the Geneious software* using a
Muscle sequence alignment28*. The resulting tree was visualized using iTOL online
tool in the circular tree mode and rooted at native KIVD29,30.
Synthetic genes coding for each GEO were synthesized as a DNA String by Life
Technologies or the Joint Genome Institute. Genes were codon-optimized for
E. coli, and the DNA as well as amino-acid sequence provided in Supplementary
Tables 3 and 4. The string was cloned into the pET-29b(þ ) plasmid vector using
the Gibson assembly between the NdeI and XhoI restriction sites that added a
C-terminal 6x-His tag in-frame to the gene.
1-Pentanol
1-Hexanol
1-Heptanol
1-Octanol
2.0
1.0
0.0
0 200 400 600 800 1,000
Ce
ll d
en
sit
y 
at
 0
D 
60
0 
nm
Alcohols supplemented (mg l–1)
Figure 9 | Toxicity as a function of alcohol chain length. The optical
density of the engineered E. coli strain after a 7-h growth was measured as a
function of the alcohol concentration added to growth media at the
beginning of incubation.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms10005 ARTICLE
NATURE COMMUNICATIONS | 6:10005 | DOI: 10.1038/ncomms10005 | www.nature.com/naturecommunications 7
*Default settings were used unless otherwise specified.
KIVD active-site redesign. In the design simulations, 10 residues in the proposed
active-site pocket were allowed to either remain native or sample any of 11 rela-
tively hydrophobic amino acids (Val, Leu, Ile, Met, Phe, His, Gly, Ala, Thr, Tyr and
Trp). The identities of amino acids at all other positions were kept constant.
Residues within 12Å of the ligand were allowed to undergo conformational
sampling during simulation. A total of 10,000 design simulations were run, from
which the 50 designs lowest in ligand–protein interface energy, and non-redundant
in terms of sequence, were selected to represent the potential sequence space
predicted to accommodate the C8 substrate. The profile was used to construct a
small library ofB400 KIVD mutants. Each amino acid in the library was sampled
as a single mutation, with the exception of residues that were within five residues
from one another. These were sampled in a combinatorial manner as both single
and double mutants to evaluate synergistic effects, given their proximity to one
another. A complete list of oligos and the amino acids allowed for each site are
provided in the Supplementary Tables 5 and 6.
Construction and selection of KIVD libraries. All E. coli strains and plasmids
used are listed in Supplementary Table 7. Partially degenerate oligonucleotides
(Supplementary Table 6) were ordered from Integrated DNA Technologies (San
Diego, CA) and were used to generate libraries of kivd mutants (with N-terminal
histidine tags) using PCR. Library DNA was purified, inserted into the PCR-
amplified pQE9 vector by isothermal Gibson assembly31 and transformed into
XL1-Blue cells. Individual ampicillin-resistant colonies were picked and grown in
96-well blocks at 37 C overnight. The number of colonies picked was three times
the theoretical library size to ensure B95% probability of all possible mutation
combinations occurring. Glycerol was added to 25% (w/v) and libraries were stored
at  80 C until enzyme activity and specificity were assayed. KIVD mutant
libraries were screened using a pH-monitored enzyme assay (method explained
below) to measure the rate of Hþ consumption resulting from the decarboxylation
of 2-ketoacids.
KIVD mutant libraries were grown overnight in culture blocks, diluted 1:100
into fresh media (Luria Broth), grown at 37 C for 3 h to OD600B0.6, induced with
0.1mM isopropyl-b-D-thiogalactoside (IPTG; GoldBio, Saint Louis, MO) and
grown for two additional hours at 37 C. Cells from the well blocks were
transferred to 96-well assay plates (Costar, Corning, NY) and cell density was
measured at 600 nm. An equal volume of permeabilization solution (8.7mM
potassium phosphate, 43.4mM KCl, 0.87mM MgSO4, pH 7.1±0.1, 8.7% (v/v)
chloroform, 0.0043% (w/v) SDS and 0.26% (v/v) 2-mercaptoethanol) was then
added to break the cell membranes. Bromothymol blue, TPP (Sigma-Aldrich, St
Louis, MO) and substrate were added to 0.008% (w/v), 0.5 and 10mM, respectively.
All substrates (2-ketobutyrate, 2-ketovalerate, 2-ketoisovalerate, 2-ketocaproate
and 2-ketooctanoate; Sigma-Aldrich) were dissolved in MilliQ dH2O and pH was
adjusted to 7.1±0.1. Absorbance was measured at 615 nm in a spectrophotometer
(TEK Powerwave XS, BioTek, Winooski, VT). Data were acquired for 15min at
30 C. Cells containing pQE_hiskivd_wt and pQE9 were used as positive and
negative controls, respectively. Enzyme activity data were corrected for cell density.
Mutants chosen from this screening had a 25% higher activity than wild-type
KIVD for any of the 2-ketoacids.
The library derived from the pH-coupled assay was further screened using a
second enzyme kinetics assay. This assay involved a second enzyme, ADH from
S. Cerevisiae (ADH6), which is a key enzyme in the alcohol production pathway in
reducing the aldehyde produced by KIVD into an alcohol. ADH couples oxidation
of NADPH to NADPþ to the reduction of aldehyde into an alcohol.
Stoichiometrically, conversion of 1M of 2-ketoacid to n-alcohol depletes exactly
1M of NADPH. Therefore, activity of KIVD could be measured directly by
measuring depletion of NADPH through ultraviolet spectrophotometry.
Overnight cultures of XL1B with pQE9 containing KIVD mutations were grown
at 37 C in a 96-well block. Cultures were diluted 1:100 and then grown for 3 h at
37 C to OD600 of 0.6. Cultures were induced with 0.1mM IPTG (GoldBio) for 3 h
at 37 C. Cultures were then centrifuged, and pellets were lysed with BugBuster
(Novagen, Madison, WI). Cell lysate (5ml) from each culture and a buffer mix
(175 ml) containing coenzyme 1.5mM TPP (Sigma), 0.2mM NADPH (Fisher
Scientific, Waltham, MA), 0.045U ADH6, 100mM NaPO4, 100mM NaCl and
10mM MgCl2, pH of 7, were added together into a 96-well plate. In all, 20 ml of
100mM substrate was added to dilute to make a final concentration of 10mM. The
substrates tested were IsoC5, C4, C5, C6, C8 and H2O (Supplementary Fig. 2).
Absorbances were measured with a plate reader (TEK Powerwave XS, BioTek) at
340 nm at 30 C for 15min. The protein concentration in each sample was
determined with a BCA assay (Thermo Scientific, Waltham, MA) and used to
normalize slope values. Candidate KIVD mutants were chosen for greater activity
on long-chained 2-ketoacids and decreased activity on shorter 2-ketoacids. This
was determined from graphing absorbance versus time for each substrate and
qualitatively comparing slope values versus wild type (Supplementary Fig. 2).
Site-directed mutagenesis. Oligonucleotides (Supplementary Table 6) encoding
specific kivd mutations were ordered from Integrated DNA Technologies (Coral-
ville, Iowa) and were used to mutate kivd in pZE_LeuA*BCDKA6 and
pQE_hiskivd_wt using PCR. Amplified DNA fragments were purified, inserted into
either the PCR-amplified pZE vector containing leuA*BCD and adh6 or the pQE
vector by isothermal Gibson assembly, and transformed into XL1-Blue cells.
Plasmid DNA was purified (Qiagen, Hilden, Germany) from overnight cultures of
antibiotic-resistant colonies and the plasmid sequences were verified (Laragen,
Culver City, CA).
Chromosomal gene knockout. Genes were removed from the ATCC 98082 DrhtA
strain genome using P1 transduction from the Keio collection as previously
described32. The aldehyde-ADH gene (adhE) was knocked out to eliminate ethanol
production from acetyl-coA. In all strains, recA was knocked out to prevent
recombination between the genome and plasmids, thereby stabilizing the
transformants. Primers used to target recA for knockout (Supplementary Table 6)
were designed based on the Keio collection (Genobase, http://ecoli.aist-nara.ac.jp/)
and ordered from Integrated DNA Technologies.
Fermentation procedure and analysis. For n-alcohol production, strains of
ST128 were transformed with pZS_thrO, pZAlac_ilvABSleuA and pZE_-
LeuA*BCDK*A6 containing various kivd mutations. Fermentation conditions were
adapted from those in previous lines of works3,4, with the following changes: 20ml
of medium was used, with 100mgml 1 ampicillin, 50 mgml 1 kanamycin and
100 mgml 1 spectinomycin added. Cells were grown to an optical density at
600 nm of B0.6, followed by induction with 0.1mM IPTG. After fermentation,
cells were centrifuged for 15min at 4,000g and 4 C. The supernatant was split into
two fractions for analysis, 5ml for short-chain alcohols (ethanol, 1-propanol and
1-butanol) and 15ml for longer-chain alcohols (1-pentanol, 1-hexanol, 1-heptanol
and 1-octanol). Longer-chain alcohols were extracted from the 15-ml fraction by
3ml n-hexane before analysis. GC-FID analysis was performed as previously
described4.
Protein purification and enzymatic assay of KIVD. For the native KIVD and
KIVD_VLV mutant, 2ml overnight cultures of XL1B cells were transformed with
pQE9 containing N-terminal his-tagged KIVD enzymes and grown in Terrific
Broth (BP Biomedical, Cat# 3046-042) with 50 mgml 1 of carbenicillin (Fisher
Scientific, Cat# BP2648-5). For the GEOs, 2-ml overnight cultures of BLR cells
were transformed with pet29bþ plasmid containing N-terminal his-tagged GEOs,
and grown in Terrific Broth with 50 mgml 1 of kanamycin (Fisher Scientific, Cat#
BP906-5). These cultures were diluted 1:1,000 in 500ml of Terrific Broth with
1mM MgSO4, 1% glucose and 50 mgml 1 of corresponding antibiotics, and then
grown at 37 C for 24 h. Cultures were pelleted down at 4,700 r.p.m. for 10min and
resuspended in auto-induction media (LB broth, 1mM MgSO4, 0.1mM TPP,
1 NPS and 1 5052) for induction at 18 oC for 34 h. At the end of induction,
cells were centrifuged (4,700 r.p.m., 4 C, 20min), supernatant was removed
and cells were resuspended in 40ml lysis buffer (100mM Hepes, pH 7.5, 100mM
NaCl, 10% glycerol, 0.1mM TPP, 1mM MgSO4, 10mM Imidazole, 1mM TCEP)
and 1mM phenylmethylsulphonyl fluoride and sonicated for 2min. Lysed cells
were centrifuged at 4,700 r.p.m. at 4 oC for 60min to remove cell debris. Super-
natant was loaded on gravity flow column with 700 ml of cobalt slurry (Fisher
Scientific, CAT# PI-90091) washed with 10ml of wash buffer (100mM Hepes,
pH 7.5, 100mM NaCl, 10% glycerol, 0.1mM TPP, 1mMMgSO4, 10mM Imidazole
and 1mM TCEP). Cobalt bead bed was washed with 15ml of wash buffer five times
and proteins were eluted with 1,000 ml of elution buffer (100mM Hepes, pH 7.5,
100mM NaCl, 10% glycerol, 0.1mM TPP, 1mM MgSO4, 200mM Imidazole and
1mM TCEP). Protein samples were immediately buffer-exchanged with spin
concentrators (Satorius, CAT# VS0112) into storage buffer (100mM Hepes, pH
7.5, 100mM NaCl, 10% glycerol, 0.1mM TPP, 1mM MgSO4 and 1mM TCEP)
and stored at 4 oC until kinetics characterization. Protein concentrations were
determined using a Synergy H1 spectrophotometer (Biotek) by measuring absor-
bance at 280 nm using their calculated extinction coefficients with the ExPASy
ProtParam Tool33. All other buffers and salts were purchased from Fisher
Scientific, unless otherwise specified.
The kcat and KM values of selective KIVD mutants were measured for the
substrates C3, isoC5 and C8. All substrates were dissolved in MilliQ H2O and pH
was adjusted to 7.5 as necessary. Activity was measured at 0.005–10mM substrates.
The assay was performed in a 96-well half-area plate. Each reaction contains a final
concentration of 0.5mM NADH, 1mM dithiothreitol, 0.1mM TPP, 1mMMgSO4,
reaction buffer (100mM Hepes, 100mM NaCl, 10% glycerol, pH 7.5) and ADH
(Sigma-Aldrich, A7011, 10Uml 1 for C3, C5 and C8 reactions, 500Uml 1 for
isoC5 reactions). A wide range of ketoacid decarboxylase concentrations, 4.5 nM–
15 mM, was used according to the activity of each enzyme towards different
substrates to perform steady-state kinetics measurement over a period of an hour.
Absorbance readings were taken every 1min at OD340 at 21 C for 60min using the
Synergy H1. Kinetic parameters (kcat and KM) were determined by fitting initial
velocity versus substrate concentration data to the Michaelis–Menten equation.
Alcohol toxicity. Alcohol tolerance of the in vivo alcohol production strain was
evaluated by supplementing the fermentation media with specified quantities of
longer-chain alcohols, and measuring growth over 7 h. Both the E. coli strain
(ATCC 98082 pZS_thrO, pZAlac_ilvA_LeuA and
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pZE12LeuA*BCDKA6_KIVD_wt) and fermentation media (1X M9 metalsþ 1X
trace metal mixþ 0.5% yeast extractþ 2% glucoseþ antibiotics) and conditions are
the same as described above (Fermentation procedure and analysis). Cells were
grown in media without IPTG induction to a starting OD600B0.02 and then
supplemented with either 1-petanol, 1-hexanol, 1-heptanol or 1-octanol at specified
concentrations of 10, 50, 250, 500 or 1,000mg l 1. OD600 readings were taken
hourly up to 7 h. Figure 9 shows the final OD600 recorded at 7 h.
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